Transport and Detoxication: Principles, Approaches, and Perspectives for Research on the Blood – Brain Barrier

Abstract

The blood–brain barrier is an anatomical constraint that maintains homeostasis within the brain and consists of uniquely structured brain capillaries. In addition to these morphological features, a number of specific proteins and transport systems (which are relevant to pharmaceutical applications) can be described that complement barrier functions and ensure a selective supply of substances from the blood to the brain. The additional role of the blood–brain barrier as a site of active detoxication by metabolizing and thus defending against neurotoxic substances has only become apparent in the past few years. Fundamental to understanding these processes are the principles of detoxication reactions and metabolic pathways of excretory organs, which will be described briefly here. The confirmation of these mechanisms in the brain enhances understanding of the complex protective functions of the blood–brain barrier. Evidently, these detoxication pathways simultaneously produce metabolites with neurotoxic or, in case of leukotriene, blood–brain barrier damaging potential. Finally, a detailed description of the mercapturic acid pathway of detoxication will be used to illustrate how evidence of representative enzymes can be used to distinguish definite functions of particular cell types and marker proteins of the blood–brain barrier.

Bifunctional Peptide-Based Opioid Agonist–Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain

“…Moreover, as it is known, the BBB is also an enzymatic barrier, 69,70 and in this regard we observed an increased resistance to proteases for compounds 8 and 13a thanks to the N -terminal capping either with an acetyl or the opioid pharmacophore, respectively.…”

Biodistribution of Stealth and Non-stealth Solid Lipid Nanospheres after Intravenous Administration to Rats

“…TEM analysis con®rmed the results obtained with labelled SLNs. Both kinds of SLN were detected in the CSF; probably their small size and their composition facilitated their passage across the blood± brain barrier, and their physicochemical nature may have made them compatible with blood± brain-barrier transport systems (Aigner et al 1997). Bargoni et al (1998) used TEM analysis to show that after administration SLNs maintained their spherical shape and size in lymph and plasma.…”

The Role of P-glycoprotein in Preventing Developmental and Neurotoxicity

“…In the human, the microvasculature, which includes an estimated 40 billion capillaries, serves as a site of chemical exchange between tissue and blood (Aigner et al, 1997). These capillaries consist of a single layer of endothelial cells (continuous, discontinuous, and fenestrated) sup ported by a basement membrane.…”